Gildan Activewear (GIL) Earnings Analysis
Gildan Activewear (GIL) next reports earnings on 2026-07-30, consensus EPS 1.11 USD. Last quarter (2026-04-30) it beat with EPS 0.43 USD vs 0.36 USD est (+19.4%). It has beaten estimates in 4/6 recent quarters (67%). Trailing P/E 31.15.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does GIL next report earnings?
| Next earnings date | 2026-07-30 |
|---|---|
| Consensus EPS estimate | 1.11 USD |
| Revenue estimate | 1.61B |
GIL earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-04-30 | 0.43 USD | 0.36 USD | +19.4% | Beat |
| 2026-02-26 | 0.96 USD | 1.31 USD | -26.7% | Miss |
| 2025-07-31 | 0.97 USD | 0.96 USD | +1% | Beat |
| 2025-02-19 | 0.83 USD | 1.13 USD | -26.5% | Miss |
| 2024-10-31 | 0.85 USD | 0.85 USD | 0% | Beat |
| 2024-08-01 | 0.74 USD | 0.72 USD | +2.8% | Beat |
Beat rate: 4/6 (67%) over reported quarters with consensus data.
GIL valuation and analyst view
| Trailing P/E | 31.15 |
|---|---|
| Trailing EPS | 1.346 USD |
| Price / book | 2.89 |
| Dividend yield | 1.78% |
| Market cap | 8.21B |
| Analyst consensus | Buy (16 buy / 11 hold / 2 sell) |
| Avg price target | 71 USD |
Related research pages
Frequently asked questions
When is Gildan Activewear (GIL)'s next earnings date?
Gildan Activewear is next scheduled to report on 2026-07-30, with a consensus EPS estimate of 1.11 USD and revenue estimate of 1.61B.
Did GIL beat earnings last quarter?
In its 2026-04-30 report, GIL posted EPS of 0.43 USD versus a 0.36 USD estimate — a beat of 19.4%.
What is GIL's earnings track record?
Over the last 6 reported quarters with consensus data, GIL beat estimates 4 times (67%).
What is GIL's current P/E ratio and EPS?
GIL trades at a trailing P/E of 31.15 on trailing EPS of 1.3461018589528944 USD.
What do analysts rate GIL?
Analyst consensus is "Buy" across 29 ratings (0 strong buy, 16 buy, 11 hold, 2 sell, 0 strong sell). Average 12-month price target: 71 USD.